GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » Buyback Yield %

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Buyback Yield % : 0.00 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Oxford Cannabinoid Technologies Holdings's current buyback yield was 0.00%.


Oxford Cannabinoid Technologies Holdings Buyback Yield % Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Buyback Yield % Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Buyback Yield %
- - - -43.60 -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Buyback Yield % Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Buyback Yield %

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Buyback Yield % falls into.



Oxford Cannabinoid Technologies Holdings Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Oxford Cannabinoid Technologies Holdings's Buyback Yield for the fiscal year that ended in Apr. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 13.7339488
=0.00%

Oxford Cannabinoid Technologies Holdings's annualized Buyback Yield for the quarter that ended in Oct. 2023 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 2 / 6.963016
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Oct. 2023) data.


Oxford Cannabinoid Technologies Holdings Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Headlines

No Headlines